50,000 Shares in Pediatrix Medical Group, Inc. $MD Purchased by Tejara Capital Ltd

Key Points

• Tejara Capital Ltd acquired 50,000 shares of Pediatrix Medical Group, Inc. (NYSE:MD) for approximately $724,000, representing a 0.06% stake in the company.
• Pediatrix Medical Group reported earnings of $0.53 per share for the last quarter, surpassing analyst expectations of $0.42, although revenue declined 7.1% year-over-year.
• Institutional investors own about 97.71% of Pediatrix Medical Group’s stock, indicating strong institutional interest in the company.

Tejara Capital Ltd bought a new position in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 50,000 shares of the company's stock, valued at approximately $724,000. Tejara Capital Ltd owned approximately 0.06% of Pediatrix Medical Group at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the stock. LPL Financial LLC grew its position in Pediatrix Medical Group by 4.9% in the 4th quarter. LPL Financial LLC now owns 92,828 shares of the company's stock valued at $1,218,000 after buying an additional 4,295 shares in the last quarter. Geode Capital Management LLC raised its position in Pediatrix Medical Group by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 1,947,796 shares of the company's stock valued at $25,562,000 after acquiring an additional 11,045 shares in the last quarter. Wells Fargo & Company MN raised its position in Pediatrix Medical Group by 11.0% during the fourth quarter. Wells Fargo & Company MN now owns 66,028 shares of the company's stock valued at $866,000 after acquiring an additional 6,521 shares in the last quarter. Legal & General Group Plc grew its holdings in Pediatrix Medical Group by 2.2% during the fourth quarter. Legal & General Group Plc now owns 238,935 shares of the company's stock valued at $3,135,000 after purchasing an additional 5,033 shares during the last quarter. Finally, Renaissance Technologies LLC increased its position in Pediatrix Medical Group by 117.4% during the fourth quarter. Renaissance Technologies LLC now owns 838,800 shares of the company's stock worth $11,005,000 after acquiring an additional 453,000 shares during the period. 97.71% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. Zacks Research upgraded shares of Pediatrix Medical Group to a "strong-buy" rating in a research note on Monday, August 11th. UBS Group increased their target price on Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a research note on Thursday, August 14th. Finally, Macquarie increased their price objective on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a report on Thursday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat, Pediatrix Medical Group presently has a consensus rating of "Moderate Buy" and an average price target of $16.75.

Pediatrix Medical Group Trading Up 3.0%

MD traded up $0.4810 on Tuesday, hitting $16.4810. 1,019,496 shares of the company were exchanged, compared to its average volume of 752,390. Pediatrix Medical Group, Inc. has a 12 month low of $10.06 and a 12 month high of $17.67. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.80 and a current ratio of 1.80. The firm has a fifty day simple moving average of $13.58 and a two-hundred day simple moving average of $13.86. The stock has a market capitalization of $1.44 billion, a PE ratio of 12.78 and a beta of 1.21.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.42 by $0.11. The business had revenue of $468.84 million during the quarter, compared to analysts' expectations of $464.37 million. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The firm's quarterly revenue was down 7.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.34 earnings per share. Sell-side analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.